176 related articles for article (PubMed ID: 37004409)
1. Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.
Schneier FR; Feusner J; Wheaton MG; Gomez GJ; Cornejo G; Naraindas AM; Hellerstein DJ
J Psychiatr Res; 2023 May; 161():364-370. PubMed ID: 37004409
[TBL] [Abstract][Full Text] [Related]
2. Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial.
Enander J; Andersson E; Mataix-Cols D; Lichtenstein L; Alström K; Andersson G; Ljótsson B; Rück C
BMJ; 2016 Feb; 352():i241. PubMed ID: 26837684
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of fluvoxamine in body dysmorphic disorder.
Phillips KA; Dwight MM; McElroy SL
J Clin Psychiatry; 1998 Apr; 59(4):165-71. PubMed ID: 9590666
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
Phillips KA; Albertini RS; Rasmussen SA
Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939
[TBL] [Abstract][Full Text] [Related]
5. Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial.
Wilhelm S; Phillips KA; Didie E; Buhlmann U; Greenberg JL; Fama JM; Keshaviah A; Steketee G
Behav Ther; 2014 May; 45(3):314-27. PubMed ID: 24680228
[TBL] [Abstract][Full Text] [Related]
6. An open-label study of citalopram in body dysmorphic disorder.
Phillips KA; Najjar F
J Clin Psychiatry; 2003 Jun; 64(6):715-20. PubMed ID: 12823088
[TBL] [Abstract][Full Text] [Related]
7. An open-label trial of venlafaxine in body dysmorphic disorder.
Allen A; Hadley SJ; Kaplan A; Simeon D; Friedberg J; Priday L; Baker BR; Greenberg JL; Hollander E
CNS Spectr; 2008 Feb; 13(2):138-44. PubMed ID: 18227745
[TBL] [Abstract][Full Text] [Related]
8. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Carhart-Harris RL; Bolstridge M; Rucker J; Day CM; Erritzoe D; Kaelen M; Bloomfield M; Rickard JA; Forbes B; Feilding A; Taylor D; Pilling S; Curran VH; Nutt DJ
Lancet Psychiatry; 2016 Jul; 3(7):619-27. PubMed ID: 27210031
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Multimodal Treatment for Young People With Body Dysmorphic Disorder in Two Specialist Clinics.
Rautio D; Gumpert M; Jassi A; Krebs G; Flygare O; Andrén P; Monzani B; Peile L; Jansson-Fröjmark M; Lundgren T; Hillborg M; Silverberg-Mörse M; Clark B; Fernández de la Cruz L; Mataix-Cols D
Behav Ther; 2022 Sep; 53(5):1037-1049. PubMed ID: 35987534
[TBL] [Abstract][Full Text] [Related]
10. Internet-based, therapist-guided, cognitive-behavioural therapy for body dysmorphic disorder with global eligibility for inclusion: an uncontrolled pilot study.
Gentile AJ; La Lima C; Flygare O; Enander J; Wilhelm S; Mataix-Cols D; Rück C
BMJ Open; 2019 Mar; 9(3):e024693. PubMed ID: 30904854
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a naturalistic 2-year follow-up after a randomised controlled trial.
Enander J; Ljótsson B; Anderhell L; Runeborg M; Flygare O; Cottman O; Andersson E; Dahlén S; Lichtenstein L; Ivanov VZ; Mataix-Cols D; Rück C
BMJ Open; 2019 Jan; 9(1):e024307. PubMed ID: 30647044
[TBL] [Abstract][Full Text] [Related]
12. Seeing in the Mind's eye: Imagery rescripting for patients with body dysmorphic disorder. A single case series.
Ritter V; Stangier U
J Behav Ther Exp Psychiatry; 2016 Mar; 50():187-95. PubMed ID: 26298841
[TBL] [Abstract][Full Text] [Related]
13. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
Phillips KA; McElroy SL; Dwight MM; Eisen JL; Rasmussen SA
J Clin Psychiatry; 2001 Feb; 62(2):87-91. PubMed ID: 11247107
[TBL] [Abstract][Full Text] [Related]
14. Acceptance-Based Exposure Therapy for Body Dysmorphic Disorder: A Pilot Study.
Linde J; Rück C; Bjureberg J; Ivanov VZ; Djurfeldt DR; Ramnerö J
Behav Ther; 2015 Jul; 46(4):423-31. PubMed ID: 26163707
[TBL] [Abstract][Full Text] [Related]
15. Therapist-guided, Internet-based cognitive-behavioural therapy for body dysmorphic disorder (BDD-NET): a feasibility study.
Enander J; Ivanov VZ; Andersson E; Mataix-Cols D; Ljótsson B; Rück C
BMJ Open; 2014 Sep; 4(9):e005923. PubMed ID: 25256187
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: a randomised controlled trial.
Veale D; Anson M; Miles S; Pieta M; Costa A; Ellison N
Psychother Psychosom; 2014; 83(6):341-53. PubMed ID: 25323062
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive antipsychotic in the treatment of body dysmorphic disorder - A retrospective naturalistic case note study.
Rashid H; Khan AA; Fineberg NA
Int J Psychiatry Clin Pract; 2015 Jun; 19(2):84-9. PubMed ID: 25363200
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of App-Based Cognitive Behavioral Therapy for Body Dysmorphic Disorder with Coach Support: Initial Randomized Controlled Clinical Trial.
Wilhelm S; Weingarden H; Greenberg JL; Hoeppner SS; Snorrason I; Bernstein EE; McCoy TH; Harrison OT
Psychother Psychosom; 2022; 91(4):277-285. PubMed ID: 35588706
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Posttreatment Effects of Therapist-Delivered Cognitive Behavioral Therapy vs Supportive Psychotherapy for Adults With Body Dysmorphic Disorder: A Randomized Clinical Trial.
Wilhelm S; Phillips KA; Greenberg JL; O'Keefe SM; Hoeppner SS; Keshaviah A; Sarvode-Mothi S; Schoenfeld DA
JAMA Psychiatry; 2019 Apr; 76(4):363-373. PubMed ID: 30785624
[TBL] [Abstract][Full Text] [Related]
20. A Pilot Randomized Controlled Trial of Cognitive-Behavioral Therapy for Adolescents With Body Dysmorphic Disorder.
Mataix-Cols D; Fernández de la Cruz L; Isomura K; Anson M; Turner C; Monzani B; Cadman J; Bowyer L; Heyman I; Veale D; Krebs G
J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):895-904. PubMed ID: 26506580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
